| Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc |
| Journal website https://jocmr.elmerjournals.com |
Review
Volume 18, Number 8, August 2026, pages 515-527
Application Progress of Machine Learning in Prognostic Prediction of Percutaneous Coronary Intervention: A Systematic Review
Tables
| Prediction model | Sample size | Core evaluation index | Sensitivity | Specificity | Key prognostic factors |
|---|---|---|---|---|---|
| PCI: percutaneous coronary intervention; AUC: area under the receiver operating characteristic curve; C-statistic: concordance statistic; GRACE: Global Registry of Acute Coronary Events; SVM: support vector machine; STEMI: ST-segment elevation myocardial infarction. | |||||
| GRACE score (traditional) | 21,237 | C-statistic = 0.83 | — | — | Conventional clinical indicators |
| Random forest | 21,237 | C-statistic = 0.92 | — | — | Age, renal function, hemodynamic status |
| SVM | 1,895 STEMI patients | AUC = 0.94 | 91.2% | 88.7% | Creatinine level, left ventricular ejection fraction, cardiogenic shock |
| Deep neural network | Large-sample dataset | AUC = 0.94 | — | — | Albumin level, lymphocyte count, conventional indicators |
| Prediction model | Prediction cycle | Core evaluation indicators | Core advantages |
|---|---|---|---|
| PCI: percutaneous coronary intervention; MACEs: major adverse cardiovascular events; C-index: concordance index; XGBoost: extreme gradient boosting; SHAP: SHapley Additive exPlanations; AUC: area under the receiver operating characteristic curve; F1: F1-score; GRACE: Global Registry of Acute Coronary Events. | |||
| GRACE score (traditional) | 1-year | C-index = 0.71 | Simple operation, limited ability to capture nonlinear relationships |
| Random forest | 1-year | C-index = 0.78 | Stable performance, accurate screening of key risk factors |
| XGBoost | 30-day | Precision = 0.89, recall = 0.85, F1 = 0.87 | Excellent for imbalanced datasets, interpretable via SHAP |
| Multimodal deep learning | 5-year | AUC = 0.83 (traditional clinical model: AUC = 0.76) | Integrate imaging and clinical data, high long-term prediction accuracy |
| Prediction model | AUC | Sensitivity | Specificity | Model characteristics |
|---|---|---|---|---|
| PCI: percutaneous coronary intervention; AUC: area under the receiver operating characteristic curve; CRUSADE: Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines; LSTM: long short-term memory. | ||||
| CRUSADE score (traditional) | 0.64 | — | — | Low accuracy, unable to process high-dimensional variables |
| Single random forest | 0.76 | — | — | Adaptable to high-dimensional clinical variables |
| Ensemble voting classifier | 0.81 | 78% | 76% | Integrate multiple algorithms with better robustness |
| LSTM time-series model | — | 85% (accuracy) | — | Dynamic real-time risk assessment within 72 h after PCI |
| Prediction model | Prediction term | C-index | Core advantages | Limitations |
|---|---|---|---|---|
| PCI: percutaneous coronary intervention; C-index: concordance index; RSF: random survival forest. | ||||
| Cox proportional hazards regression | 5-year | 0.71 | Mature and classic, easy to implement | Poor capability to capture nonlinear variable interactions |
| RSF | 5-year | 0.76 | Effectively capture nonlinear relationships between variables | Limited ability to mine ultra-high-dimensional data |
| DeepSurv deep learning model | 10-year | 0.82 | Adapt to high-dimensional variables such as genetic loci with high long-term prediction accuracy | Poor model interpretability |
| Algorithm type | Applicable data characteristics | Core advantages | Main application scenarios |
|---|---|---|---|
| PCI: percutaneous coronary intervention; SVM: support vector machine; XGBoost: extreme gradient boosting; MLP: multilayer perceptron; CNN: convolutional neural network; LSTM: long short-term memory; MACEs: major adverse cardiovascular events; ECG: electrocardiogram; STEMI: ST-segment elevation myocardial infarction; SHAP: SHapley Additive exPlanations. | |||
| Random forest | Large-sample and high-dimensional data with missing values | Automatic feature selection, strong robustness, partial interpretability | In-hospital mortality, bleeding risk, medium-term MACE prediction |
| SVM | Small-sample nonlinear datasets | Superior small-sample performance, good generalization ability | In-hospital mortality prediction of STEMI patients |
| XGBoost | Large-scale and imbalanced clinical data | Anti-overfitting, high training efficiency, SHAP-based interpretability | Short-term MACEs prediction, imbalanced sample prediction tasks |
| MLP | High-dimensional structured clinical data | Automatically learn nonlinear feature interactions | General prognostic prediction tasks |
| CNN | Grid-based medical image data | Automatic medical imaging feature extraction | Feature analysis of coronary angiography, ECG and echocardiography |
| LSTM | Time-series dynamic monitoring data | Capture long-term dynamic data dependencies | Dynamic postoperative bleeding risk assessment |
| DeepSurv | High-dimensional omics and survival data | Mine novel genetic prognostic biomarkers | Long-term survival prediction of PCI patients |
| Advantages | Disadvantages |
|---|---|
| PCI: percutaneous coronary intervention. | |
| Can identify nonlinear and high-dimensional relationships between variables | Limited interpretability of complex deep learning models (“black box”) |
| Able to fuse multimodal data (clinical indicators, imaging, time-series signals) | Performance is susceptible to data quality, missing values and inconsistent data standards |
| Outperforms traditional linear risk scores on most prognostic endpoints | Model performance frequently declines during external validation (domain shift) |
| Flexible algorithms suitable for classification, survival analysis and imbalanced data tasks | Requires computational resources and professional analytical expertise |
| Outputs individualized risk probabilities to support precision treatment | Lack of unified standards for modeling, verification and clinical deployment |